Investor Relations

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.

Stock Quote

Price / Change

30.19

0.64

Ticker:
HPTX
Exchange:
NASDAQ
Day High:
30.35
Day Low:
29.48
Volume:
334,800

3:11 PM ET on March 2, 2015
Delayed at least 20 minutes.
Provided by eSignal.